Who we are

“In a bid to reduce the inevitable following an early stage pancreatic cancer diagnosis, I decided to concentrate my life mission on helping patients establish effective solutions for cancer.

– Mark Sean Taylor, founder

The initiative is led by Mark Sean Taylor, who has spent 20 years working in finance and technology, working in London, New York, Hong Kong, Istanbul and Sao Paulo. Diagnosed with minimal residual disease pancreatic cancer through circulating tumour cells in 2016.

He was rejected for standard of care medicine, as the level of cancer was below what mainstream medicine recognise for a formal diagnosis. This forced him into integrative medicine as an initial skeptic. He has since spent over $500,000 USD on treatments and tests at some of the top medical institutions around the world, learning the approaches of some of the world leading integrative doctors.

After starting the patient led oncology trials facebook group, tracking the responses of hundreds of cancer patients progress following almost every well known integrative cancer treatment, he has identified effective approaches to cancer treatment that work well, supported by data, patient reports and research to back up the approaches. He is an avid cancer researcher that now works with an advises some of the top integrative cancer clinics over the world. He blogs about his findings through: https://www.facebook.com/groups/patientledoncologytrials

“within the next 5 to 10 years, cancer will become as manageable as diabetes is today. “

– Gabriele Gavazzi, researcher and author

Gabriele's biography is a story of resilience, intellectual curiosity, and a deep personal connection to the fight against cancer. Armed with a Master's in Mathematical Finance and a passion for science, particularly biology, Gabriele ventured into the entrepreneurial world, establishing a company specializing in dermatology and medical device furnishings.

Gabriele's move to become a cancer researcher and volounteer for Patient Led Oncology Trials was inspired not just by a love for science but also by a profound personal history with cancer affecting many family members.

The turning point in Gabriele's research journey came three years ago when his grandmother, aged 85, was diagnosed with Stage 2 colorectal cancer. After a successful yet taxing surgery, a secondary issue emerged: a 5 cm lesion on her neck. The diagnosis of metastasis came as a shock, with the oncologist predicting two months maximum left for her. Recognizing the impact of nocebo effect on prognosis and morale, especially in the later years of life, Gabriele took it upon himself to soften the translation of the diagnosis to his grandmother. This decision marked the beginning of an intensive research journey.

Diving deep into over 3000 studies, with a focus on off-label use, immunotherapy, and autologous cell therapies, Gabriele sought to empower himself with knowledge. His research culminated in the development of three innovative rainbow protocols, which he later shared with the world, hoping to offer hope and empowerment to others battling cancer.

Gabriele's grandmother, after undergoing an off-label regimen, IV polyphenols, IV vitamin C, and cryoablation of the mass, passed away peacefully from natural causes more than two years later. She was spared from the constant dread of impending death that would have occurred if her oncologist was followed blindly.

Meeting Mark and his group further inspired Gabriele. He recognized a significant gap in the healthcare system: the need for a bridge between the intricate world of medical research and the practical, everyday needs of patients. This realization led him to author a book aimed at demystifying cancer treatment and research, presenting complex information in an accessible manner. His vision is to empower patients to take control of their destinies and understand the powerful tools at their disposal.

Gabriele firmly believes that, within the next 5 to 10 years, cancer will become as manageable as diabetes is today. His story is one of hope, empowerment, and the conviction that individuals can indeed influence their health outcomes.

interview with Mark Sean Taylor on Cancer Patient lab about his personal experience, Patient Led Oncology and its findings.